Literature DB >> 23075397

Crystal structure of greglin, a novel non-classical Kazal inhibitor, in complex with subtilisin.

Chrystelle Derache1, Christophe Epinette, Alain Roussel, Guillaume Gabant, Martine Cadene, Brice Korkmaz, Francis Gauthier, Christine Kellenberger.   

Abstract

Greglin is an 83-residue serine protease inhibitor purified from the ovaries of the locust Schistocerca gregaria. Greglin is a strong inhibitor of subtilisin and human neutrophil elastase, acting at sub-nanomolar and nanomolar concentrations, respectively; it also inhibits neutrophil cathepsin G, α-chymotrypsin and porcine pancreatic elastase, but to a lesser extent. In the present study, we show that greglin resists denaturation at high temperature (95 °C) and after exposure to acetonitrile and acidic or basic pH. Greglin is composed of two domains consisting of residues 1-20 and 21-83. Mass spectrometry indicates that the N-terminal domain (1-20) is post-translationally modified by phosphorylations at three sites and probably contains a glycosylation site. The crystal structure of the region of greglin comprising residues 21-78 in complex with subtilisin was determined at 1.75 Å resolution. Greglin represents a novel member of the non-classical Kazal inhibitors, as it has a unique additional C-terminal region (70-83) connected to the core of the molecule via a supplementary disulfide bond. The stability of greglin was compared with that of an ovomucoid inhibitor. The thermostability and inhibitory specificity of greglin are discussed in light of its structure. In particular, we propose that the C-terminal region is responsible for non-favourable interactions with the autolysis loop (140-loop) of serine proteases of the chymotrypsin family, and thus governs specificity. DATABASE: The atomic coordinates and structure factors for the greglin-subtilisin complex have been deposited with the RCSB Protein Data Bank under accession number 4GI3. STRUCTURED DIGITAL ABSTRACT: Greglin and Subtilisin Carlsberg bind by X-ray crystallography (View interaction).
© 2012 The Authors Journal compilation © 2012 FEBS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23075397     DOI: 10.1111/febs.12033

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  5 in total

1.  Crystal structure of Aedes aegypti trypsin inhibitor in complex with μ-plasmin reveals role for scaffold stability in Kazal-type serine protease inhibitor.

Authors:  Varsha Ashok Walvekar; Karthik Ramesh; Chacko Jobichen; Muthu Kannan; J Sivaraman; R Manjunatha Kini; Yu Keung Mok
Journal:  Protein Sci       Date:  2021-11-29       Impact factor: 6.725

2.  New selective peptidyl di(chlorophenyl) phosphonate esters for visualizing and blocking neutrophil proteinase 3 in human diseases.

Authors:  Carla Guarino; Monika Legowska; Christophe Epinette; Christine Kellenberger; Sandrine Dallet-Choisy; Marcin Sieńczyk; Guillaume Gabant; Martine Cadene; Jérôme Zoidakis; Antonia Vlahou; Magdalena Wysocka; Sylvain Marchand-Adam; Dieter E Jenne; Adam Lesner; Francis Gauthier; Brice Korkmaz
Journal:  J Biol Chem       Date:  2014-10-06       Impact factor: 5.157

3.  A Novel Kunitzin-Like Trypsin Inhibitor Isolated from Defensive Skin Secretion of Odorrana versabilis.

Authors:  Yanjing Dong; Daning Shi; Yuan Ying; Xinping Xi; Xiaoling Chen; Lei Wang; Mei Zhou; Qinan Wu; Chengbang Ma; Tianbao Chen
Journal:  Biomolecules       Date:  2019-06-28

4.  Purification and Characterization of a Novel Kazal-Type Trypsin Inhibitor from the Leech of Hirudinaria manillensis.

Authors:  Yanmei Lai; Bowen Li; Weihui Liu; Gan Wang; Canwei Du; Rose Ombati; Ren Lai; Chengbo Long; Hongyuan Li
Journal:  Toxins (Basel)       Date:  2016-07-23       Impact factor: 4.546

5.  Isolation and Characterization of Poecistasin, an Anti-Thrombotic Antistasin-Type Serine Protease Inhibitor from Leech Poecilobdella manillensis.

Authors:  Xiaopeng Tang; Mengrou Chen; Zilei Duan; James Mwangi; Pengpeng Li; Ren Lai
Journal:  Toxins (Basel)       Date:  2018-10-26       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.